• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期肾病患者系统性红斑狼疮发作的风险因素:一项病例对照研究。

Risk factors for systemic lupus erythematosus flares in patients with end-stage renal disease: a case-control study.

机构信息

Department of Immunology and Rheumatology and.

Department of Internal Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

出版信息

Rheumatology (Oxford). 2016 Mar;55(3):429-35. doi: 10.1093/rheumatology/kev349. Epub 2015 Sep 21.

DOI:10.1093/rheumatology/kev349
PMID:26396262
Abstract

OBJECTIVES

The aim of this study was to recognize risk factors for extrarenal SLE flares in patients with end-stage renal disease (ESRD) receiving renal replacement therapy (RRT).

METHODS

We performed a retrospective, case-control study in a tertiary care hospital in Mexico City from 1993 to 2014. Cases were lupus patients who had any extrarenal flare after RRT. Controls were SLE patients with ESRD but without flares. We recorded demographic features and clinical and immunological parameters. Differences between groups were analysed by Student's t-test. Association was assessed by the odds ratio (OR) and 95% CI. Multivariate analysis was performed by binary logistic regression.

RESULTS

Eighty-eight patients were included: 38 cases (50 flares) and 50 controls. The proportion of men was higher in cases (24 vs 8%, P = 0.029). The most common flares were haematologic (42%), mucocutaneous (38%) and articular (30%). Independent risk factors for flares included age at RRT start [OR 0.92 (95% CI 0.88, 0.96), P < 0.001], history of haematologic activity [OR 3.79 (95% CI 1.05, 13.7), P = 0.04], anti-cardiolipin IgM [OR 4.39 (95% CI 1.32, 14.6), P = 0.02] and low C4 levels [OR 9.7 (95% CI 2.49, 39.12), P = 0.001].

CONCLUSION

SLE patients continue to be at risk for extrarenal activity after RRT. The most common flare was haematologic, which correlated with the history of haematologic activity and anti-cardiolipin positivity as independent risk factors. Lower C4 levels and younger age at the beginning of RRT were also associated. Patients with these characteristics should have a closer follow-up in order to detect and treat SLE flares in a timely manner.

摘要

目的

本研究旨在识别接受肾脏替代治疗(RRT)的终末期肾病(ESRD)患者发生肾外狼疮发作的危险因素。

方法

我们在墨西哥城的一家三级护理医院进行了一项回顾性病例对照研究,时间为 1993 年至 2014 年。病例为 RRT 后发生任何肾外发作的狼疮患者。对照为患有 ESRD 但无发作的 SLE 患者。我们记录了人口统计学特征以及临床和免疫参数。通过 Student's t 检验分析组间差异。通过比值比(OR)和 95%CI 评估相关性。通过二元逻辑回归进行多变量分析。

结果

共纳入 88 例患者:38 例(50 例发作)和 50 例对照。病例组中男性比例较高(24%比 8%,P = 0.029)。最常见的发作为血液学(42%)、黏膜皮肤(38%)和关节(30%)。发作的独立危险因素包括 RRT 起始时的年龄[OR 0.92(95%CI 0.88,0.96),P < 0.001]、血液学活动史[OR 3.79(95%CI 1.05,13.7),P = 0.04]、抗心磷脂 IgM[OR 4.39(95%CI 1.32,14.6),P = 0.02]和低 C4 水平[OR 9.7(95%CI 2.49,39.12),P = 0.001]。

结论

SLE 患者在 RRT 后仍有发生肾外活动的风险。最常见的发作为血液学,这与血液学活动史和抗心磷脂阳性作为独立危险因素相关。较低的 C4 水平和 RRT 起始时的年龄较小也与狼疮发作相关。具有这些特征的患者应进行更密切的随访,以便及时发现和治疗 SLE 发作。

相似文献

1
Risk factors for systemic lupus erythematosus flares in patients with end-stage renal disease: a case-control study.终末期肾病患者系统性红斑狼疮发作的风险因素:一项病例对照研究。
Rheumatology (Oxford). 2016 Mar;55(3):429-35. doi: 10.1093/rheumatology/kev349. Epub 2015 Sep 21.
2
Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy.系统性红斑狼疮的肾外疾病活动不会因慢性肾功能不全或肾脏替代治疗而受到抑制。
J Rheumatol. 1999 Jul;26(7):1490-4.
3
Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study.系统性红斑狼疮患者终末期肾病的风险:一项基于全国人口的研究。
Int J Rheum Dis. 2016 Nov;19(11):1175-1182. doi: 10.1111/1756-185X.12828. Epub 2016 Feb 10.
4
Microbiological and immunological profile of patients with severe lupus flares related to bloodstream infections: a retrospective cohort study.与血流感染相关的重度狼疮发作患者的微生物学和免疫学特征:一项回顾性队列研究。
Lupus. 2018 Feb;27(2):312-318. doi: 10.1177/0961203317720527. Epub 2017 Jul 12.
5
Factors associated with active systemic lupus erythematosus after endstage renal disease.终末期肾病后与活动性系统性红斑狼疮相关的因素。
J Rheumatol. 1998 Aug;25(8):1520-5.
6
Renal Thrombotic Microangiopathy in Proliferative Lupus Nephritis: Risk Factors and Clinical Outcomes: A Case-Control Study.增殖性狼疮性肾炎中的肾血栓性微血管病:危险因素及临床结局:一项病例对照研究
J Clin Rheumatol. 2016 Aug;22(5):235-40. doi: 10.1097/RHU.0000000000000425.
7
Incidence of progression from newly diagnosed systemic lupus erythematosus to end stage renal disease and all-cause mortality: a nationwide cohort study in Taiwan.新诊断系统性红斑狼疮进展至终末期肾病的发生率及全因死亡率:台湾一项全国性队列研究
Int J Rheum Dis. 2013 Dec;16(6):747-53. doi: 10.1111/1756-185X.12208. Epub 2013 Nov 4.
8
A surge in anti-dsDNA titer predicts a severe lupus flare within six months.抗 dsDNA 抗体滴度升高预示着六个月内狼疮病情严重发作。
Lupus. 2014 Mar;23(3):293-8. doi: 10.1177/0961203313515763. Epub 2013 Dec 6.
9
Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.印度北部和中部儿童期起病系统性红斑狼疮患者狼疮性肾炎的预后:25年单中心经验
Lupus. 2016 Apr;25(5):547-57. doi: 10.1177/0961203315619031. Epub 2015 Dec 3.
10
Kidney Outcomes and Risk Factors for Nephritis (Flare/) in a Multiethnic Cohort of Pregnant Patients with Lupus.多民族狼疮孕妇队列中肾炎(发作/)的肾脏结局及危险因素
Clin J Am Soc Nephrol. 2017 Jun 7;12(6):940-946. doi: 10.2215/CJN.11431116. Epub 2017 Apr 11.

引用本文的文献

1
Comparison of Clinical and Laboratory Characteristics in Lupus Nephritis vs. Non-Lupus Nephritis Patients-A Comprehensive Retrospective Analysis Based on 921 Patients.狼疮性肾炎与非狼疮性肾炎患者的临床和实验室特征比较——基于921例患者的综合回顾性分析
J Clin Med. 2024 Jul 31;13(15):4486. doi: 10.3390/jcm13154486.
2
Severe lupus after two years of hemodialysis: It exists and can be serious.血液透析两年后出现严重狼疮:确实存在且病情可能严重。
Egypt J Intern Med. 2023;35(1):24. doi: 10.1186/s43162-023-00208-1. Epub 2023 Mar 30.
3
Complement as a Biomarker for Systemic Lupus Erythematosus.
补体作为系统性红斑狼疮的生物标志物。
Biomolecules. 2023 Feb 15;13(2):367. doi: 10.3390/biom13020367.
4
Real-world electronic health record identifies antimalarial underprescribing in patients with lupus nephritis.真实世界电子健康记录鉴定狼疮肾炎患者抗疟药物的处方不足。
Lupus. 2019 Jul;28(8):977-985. doi: 10.1177/0961203319856088. Epub 2019 Jun 12.
5
Sex, Symptom Severity, and Quality of Life in Rheumatology.风湿科的性别、症状严重程度和生活质量。
Clin Rev Allergy Immunol. 2019 Jun;56(3):346-361. doi: 10.1007/s12016-017-8631-6.